Off-label Bulevirtide monotherapy for chronic hepatitis D virus infection in patients with decompensated liver disease

Dietz-Fricke, Christopher; Degasperi, Elisabetta; Lampertico, Pietro; Jachs, Mathias; Reiberger, T; Grottenthaler, Julia M; Berg, Christoph P.; Herta, Toni; Bömmel, Florian van; Berg, Thomas; Reiter, Florian P.; Geier, Andreas; Sprinzl, Kathrin; Zeuzem, Stefan; Buggisch, Peter; Maasoumy, Benjamin; Cornberg, Markus; Wedemeyer, Heiner; Deterding, Katja

doi:10.1016/s0168-8278(23)00594-9

Search citation statements

Order By: Relevance

Paper Sections

Select...

F I G U R E 1 (Continued)1

Bulevirtide‐based Treatment1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Off label BLV monotherapy for CHD in 15 patients with decompensated cirrhosis has been recently reported. 44…”

Section: F I G U R E 1 (Continued)mentioning

confidence: 99%

See 1 more Smart Citation

Management of chronic HBV‐HDV patients chronic HBV‐HDV infection: A review on new management options

Buti,

Gonzalez,

Riveiro‐Barciela

et al. 2023

UEG Journal

View full text Add to dashboard Cite

Hepatitis D virus was first described by Mario Rizzeto in 1977, and it is considered chronic viral hepatitis with the poorest prognosis. Despite its discovery almost 50 years ago, progress in its diagnosis and treatment has been scarce until recent years. The approval of bulevirtide has shed some light for patients with Chronic Hepatitis D, although important gaps regarding its use in therapy as well as about the epidemiology and diagnosis of the disease need to be addressed.

show abstract

“…Off label BLV monotherapy for CHD in 15 patients with decompensated cirrhosis has been recently reported. 44…”

Section: F I G U R E 1 (Continued)mentioning

confidence: 99%

“…Off label BLV monotherapy for CHD in 15 patients with decompensated cirrhosis has been recently reported. 44 14 patients Child‐Pugh B and one Child‐Pugh A were treated. Liver function and ascites improved in four patients under BLV treatment.…”

Section: Bulevirtide‐based Treatmentmentioning

confidence: 99%